BTIG analyst Ryan Zimmerman said while the increase in approvals is promising, longer decision times may have financial implications.

Led by CEO Harry Rowland, VahatiCor is developing the A-Flux coronary sinus reducer implant for coronary microvascular dysfunction.

Brian Miller shares how he built his career, what it was like at Intuitive as the device developer grew, and advice for ...

In this issue of Medical Design & Outsourcing, we focus on the tech advances and device innovators making stroke telesurgery ...

The FDA has flagged three third-party labs that submitted device testing data that may have falsified, invalid or copied from ...

XCath might have a head start after completing the first remote mechanical thrombectomy on a patient over 120 miles away.

With an initial indication for type 2 diabetes, SaMD developer UpDoc says its platform is designed to support doctors, not ...

Ford, you may have been spending more time than most car owners at the dealership getting repairs on the automaker's dime.

"What impressed me about Ketryx was how they envisioned using AI to build safer products faster," Hawkins said.

Teleflex reported 2025 compensation for top executives, including two who left after the medtech CDMO sold off some big ...

Gen-AI company Midjourney says it will open its first AI-powered medical imaging spa offering rapid whole-body, ultrasonic CT ...

MIT researchers say that a low-cost electronic nozzle design could produce time-release drug-delivery particles efficiently ...